Citation Impact
Citing Papers
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine
2009
FOXP3 Up-regulates p21 Expression by Site-Specific Inhibition of Histone Deacetylase 2/Histone Deacetylase 4 Association to the Locus
2009
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
2012 Standout
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
2016 Standout
Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
2011 Standout
Targeted Therapy in Breast Cancer
2004
Male breast carcinoma: An evaluation of prognostic factors contributing to a poorer outcome
1996
Pan-cancer patterns of somatic copy number alteration
2013
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
RNAscope
2011 Standout
Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge
2015 Standout
A non-genetic route to aneuploidy in human cancers
2011
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
2011 Standout
Interactions in the (Pre)metastatic Niche Support Metastasis Formation
2019
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
2013 Standout
Hepatocellular carcinoma
2021 Standout
The Cancer Genome Atlas Pan-Cancer analysis project
2013 Standout
The molecular machinery of regulated cell death
2019 Standout
EGF–ERBB signalling: towards the systems level
2006 Standout
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Estrogen Receptor Analysis for Breast Cancer
2005
Targeting apoptosis in cancer therapy
2020 Standout
Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?
2005
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
2009 Standout
Male breast cancer
2006 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Male breast cancer: is the scenario changing
2008
Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib
2019
The 17q12-q21 amplicon: Her2 and topoisomerase-IIα and their importance to the biology of solid tumours
2006
Targeting DNA topoisomerase II in cancer chemotherapy
2009 Standout
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
Discovery and saturation analysis of cancer genes across 21 tumour types
2014 StandoutNature
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
2009 Standout
Breast cancer metastasis: markers and models
2005 Standout
S-phase fraction and menopausal status as the most important prognostic factors of disease-free survival for node negative patients with breast cancer. A prospective study.
2003
Prognostic Variables in Male Breast Cancer
2000
The HER-2/neu Gene and Protein in Breast Cancer 2003: Biomarker and Target of Therapy
2003
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
2017 Standout
Male Breast Cancer: A Population-Based Comparison With Female Breast Cancer
2009 Standout
Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole
2008
Breast Cancer in Men
2002 Standout
Works of Saudade André being referenced
DNA Flow Cytometry but Not Telomerase Activity as Predictor of Disease-Free Survival in pT1–2/N0/G2 Breast Cancer
2006
Correlations of cell cycle regulators (p53, p21, pRb and mdm2) and c-erbB-2 with biological markers of proliferation and overall survival in breast cancer
2005
Male Breast Cancer—A Reappraisal of Clinical and Biologic Indicators of Prognosis
2001
c-erbB-2 oncoprotein overexpression identifies a subgroup of estrogen receptor positive (ER +) breast cancer patients with poor prognosis
2001
Morphology of Male Breast Carcinoma in the Evaluation of Prognosis
1990
DNA Ploidy is an Independent Predictor of Survival in Breast Invasive Ductal Carcinoma: A Long-term Multivariate Analysis of 393 Patients
2012
Breast cancer metabolic cross-talk: Fibroblasts are hubs and breast cancer cells are gatherers of lipids
2017
Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
1999
Flow cytometric DNA hypertetraploidy is associated with unfavourable prognostic features in breast cancer.
1997